These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11239718)

  • 1. Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids.
    Beinfeld MC; Connolly K
    Neurosci Lett; 2001 Mar; 301(1):69-71. PubMed ID: 11239718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus.
    Hoffman AF; Lupica CR
    J Neurosci; 2000 Apr; 20(7):2470-9. PubMed ID: 10729327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice.
    Kathmann M; Weber B; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):50-6. PubMed ID: 11191836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes.
    Gifford AN; Bruneus M; Gatley SJ; Volkow ND
    Br J Pharmacol; 2000 Oct; 131(3):645-50. PubMed ID: 11015319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors.
    Nakazi M; Bauer U; Nickel T; Kathmann M; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):19-24. PubMed ID: 10651142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain.
    Kathmann M; Bauer U; Schlicker E; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):466-70. PubMed ID: 10431757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor activation in CA1 pyramidal cells in adult rat hippocampus.
    Kirby MT; Hampson RE; Deadwyler SA
    Brain Res; 2000 Apr; 863(1-2):120-31. PubMed ID: 10773200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A.
    Gifford AN; Ashby CR
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1431-6. PubMed ID: 8667207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
    Ameri A; Wilhelm A; Simmet T
    Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large receptor reserve for cannabinoid actions in the central nervous system.
    Gifford AN; Bruneus M; Gatley SJ; Lan R; Makriyannis A; Volkow ND
    J Pharmacol Exp Ther; 1999 Feb; 288(2):478-83. PubMed ID: 9918548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition.
    Hájos N; Freund TF
    Chem Phys Lipids; 2002 Dec; 121(1-2):73-82. PubMed ID: 12505692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells.
    Takahashi KA; Linden DJ
    J Neurophysiol; 2000 Mar; 83(3):1167-80. PubMed ID: 10712447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons.
    Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
    Br J Pharmacol; 2004 May; 142(2):257-66. PubMed ID: 15155534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat.
    Bereiter DA; Bereiter DF; Hirata H
    Pain; 2002 Oct; 99(3):547-556. PubMed ID: 12406531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats.
    Tyler K; Hillard CJ; Greenwood-Van Meerveld B
    Eur J Pharmacol; 2000 Dec; 409(2):207-11. PubMed ID: 11104836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus.
    Hoffman AF; Riegel AC; Lupica CR
    Eur J Neurosci; 2003 Aug; 18(3):524-34. PubMed ID: 12911748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids, hippocampal function and memory.
    Hampson RE; Deadwyler SA
    Life Sci; 1999; 65(6-7):715-23. PubMed ID: 10462072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
    Gerdeman G; Lovinger DM
    J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices.
    Gifford AN; Samiian L; Gatley SJ; Ashby CR
    Eur J Pharmacol; 1997 Apr; 324(2-3):187-92. PubMed ID: 9145770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons.
    Katona I; Sperlágh B; Sík A; Käfalvi A; Vizi ES; Mackie K; Freund TF
    J Neurosci; 1999 Jun; 19(11):4544-58. PubMed ID: 10341254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.